Investor Toolbox
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
ROIV Coverage
Event
Roivant Sciences (ROIV) New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
Mar 29, 2026
Transcript
Roivant Sciences (ROIV) Q2 2026 Earnings Call Transcript
Mar 10, 2026
Event
Roivant Sciences (ROIV) Sec Form 8K
Mar 5, 2026
Event
Roivant Sciences (ROIV) Sec Form 8K
Mar 5, 2026
News
Roivant Reports Q3 Results, Cites Phase 2 Breakthrough and Catalyst-Rich 2026
Feb 6, 2026
News
Roivant Sciences Reports Fiscal Third Quarter 2025 Results Amid Robust Pipeline Advancement
Feb 6, 2026
Transcript
Roivant Sciences (ROIV) Q3 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Roivant Sciences (ROIV) Q4 2025 Earnings Call Transcript
Jan 22, 2026